Neurological manifestations of immunoglobulin G<sub>4</sub> related disease: a systematic review of 393 cases.

Ng, Yau Zane Justin; Bowen, Scarlett; Phillips, Jenna; Rajasekaran, Mugil; Lu, Shi Sheng; Taylor, Bruce V · J Neurol Neurosurg Psychiatry · 2025

systematic_review · Level I

Where this comes from

Abstract

Immunoglobulin G<sub>4</sub> (IgG<sub>4</sub>) related disease (RD) is a multisystem, immunologically mediated disease discovered within the last two decades. Within the nervous system, a broad range of both central and peripheral nervous system involvement has been reported. We aimed to systematically review the neurological manifestations of IgG<sub>4</sub>-RD. To identify the clinical presentation, radiological findings, diagnostic methods, treatment and outcomes for neurological manifestations of IgG<sub>4</sub>-RD. We systematically reviewed the literature to identify all reports of neurological manifestations of IgG<sub>4</sub>-RD. Data on neurological manifestations, non-neurological manifestations, clinical presentation, radiological findings, diagnostic methods, treatment modalities and outcomes were extracted. We identified 393 cases from 297 publications meeting the inclusion criteria. Hypertrophic pachymeningitis, IgG<sub>4</sub>-related orbital disease and hypophysitis are the most common neurological manifestations of IgG<sub>4</sub>-RD. Diagnostic evaluation involves testing for concomitant non-neurological manifestations, an MRI with gadolinium contrast, measurement of serum IgG<sub>4</sub> levels and a biopsy with specific staining for IgG<sub>4</sub> positive plasma cells. Treatment with corticosteroids leads to favourable outcomes. IgG<sub>4</sub>-RD is an emerging neurological disease that can manifest in multiple ways within the nervous system. It is important to recognise as treatment is often successful.

Medical subject headings